Both in Pharmaceuticals
Seaport Therapeutics vs Maravai LifeSciences Holdings
Over the past year SPTX returned −12.7% and MRVI returned +30.2%; their daily moves had a correlation of 0.28.
SPTX −12.7% MRVI +30.2%Growth of $1, one year, split-adjusted
| Metric | SPTX | MRVI |
|---|---|---|
| Price | $20.38 | $8.50 |
| Market cap | $1.09B | $1.27B |
| Today | −4.23% | +2.91% |
| 1 month | +9.0% | +11.1% |
| 6 months | — | +144.3% |
| Year to date | — | +161.5% |
| 1 year | — | +154.5% |
| Revenue growth (YoY) | — | +8.5% |
| Gross margin | — | 40.1% |
| Net margin | — | −24.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.1× |
| Net cash | $273.3M | -$106.6M |
| Dividend yield | — | — |
| Volatility (60d) | — | 83.2% |
| Short % of float | 19.2% | 10.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).